Skip to content

Bleichroeder LP 13F Holdings · Q2 2026

Bleichroeder LP reported 78 securities worth $558.94M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: GLD (31.31%), GPGI (11.26%), SPY (9.04%). Among its top 25 positions this quarter: 2 new, 4 added, 4 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1GLDSPDR GOLD TR$175.0M31.31%475,000Hold
2GPGIGPGI INC$63.0M11.26%4.0MAdded
3SPYSTATE STR SPDR S&P 500 ETF T$50.5M9.04%67,645Hold
4RHLDRESOLUTE HLDGS MGMT INC$45.4M8.12%314,166Hold
5LINLINDE PLC$31.4M5.61%60,434Trimmed
6DUOTDUOS TECHNOLOGIES GROUP INC$19.5M3.49%1.6MHold
7DTILPRECISION BIOSCIENCES INC$15.9M2.84%2.0MAdded
8CUECUE BIOPHARMA INC$11.7M2.09%370,682New
9BXBLACKSTONE INC$10.7M1.91%90,750Hold
10IMMXIMMIX BIOPHARMA INC$10.3M1.84%1.0MHold
11IDNINTELLICHECK MOBILISA INC$8.4M1.51%2.1MTrimmed
12SPGIS&P GLOBAL INC$8.1M1.46%20,000Hold
13INVEIDENTIV INC$7.3M1.30%2.9MHold
14LIQTLIQTECH INTL INC$5.8M1.05%6.9MAdded
15KZIAKAZIA THERAPEUTICS LTD$5.6M1.01%400,000Hold
16COCHENVOY MEDICAL INC$5.0M0.89%6.2MHold
17CGEMCULLINAN THERAPEUTICS INC$4.6M0.81%250,000Added
18EYPTEYEPOINT INC$4.5M0.81%316,515Hold
19WELLWELLTOWER INC$4.5M0.81%20,000Hold
20FLNTFLUENT INC$4.3M0.76%1.1MTrimmed
21GNLXGENELUX CORPORATION$4.2M0.74%1.4MHold
22PROKPROKIDNEY CORP$4.1M0.73%2.0MHold
23COGTCOGENT BIOSCIENCES INC$3.9M0.69%100,000New
24QQQINVESCO QQQ TR$3.4M0.61%4,640Hold
25JPMJPMORGAN CHASE & CO$3.3M0.60%10,200Trimmed

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR